Jpmorgan Chase & CO Profound Medical Corp. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Shares
3 transactions
Others Institutions Holding PROF
# of Institutions
45Shares Held
8.93MCall Options Held
1.2KPut Options Held
5K-
Fil LTD Hamilton, D01.54MShares$11.5 Million0.01% of portfolio
-
Gagnon Securities LLC1.47MShares$11 Million2.46% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.2MShares$9.01 Million0.18% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL760KShares$5.72 Million0.01% of portfolio
-
Timelo Investment Management Inc.752KShares$5.65 Million3.75% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $157M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...